Professional Documents
Culture Documents
March 27-28, 2021
March 27-28, 2021
Dr. Amante/Hizon/Hermogino
7 MORTALITIY 1
DISCHARGE
SERVICE IN PATIENT
830 AV Massive Pleural Effusion, Diet: DAT For Pleurodesis Dr. Gervasio
REF 29/M Left; Left Lower Lung Mass IVF: PNSS 1L x 40cc/hr Dr.Arandia
t/c CA Meds: Etoricoxib 120 mg OD, Tramadol 50 mg Q6, Paracetamol+Tramadol 50 mg TID
3/14/21 s/p VATS, Right Labs:
3/18/21 POD 9
s/p CT-guided lung mass
biopsy (3/23/21)
840 JR Milliary TB, Thoracic Diet DAT (exclude apple and banana) Dr. N. Cruz/ Dr. Castillo
ER 33/M spondylosis IVF: HL
s/p CT guided drainage of Meds: Pregabalin 75mg BID, Dexamethasone 4mg PO TID, Paracetamol 500 mg PO, Omeprazole 40 mg PO, HRZE, Levofloxacin 500mg OD,
1/28/21 paraspinal abscess 3/18/21 Lactulose 30ml ODHS, Dexamethasone 4mg BID
POD6 2/20/21: Crea 0.60/ Na 145/ K 3.98/ eGFR Crea 132.1/ AST 24.0/ Mg 2.10/ ALT 18/
2/20/21: WBC 10.3/ Neutro 82/ Hgb 10.6/ Hct 33.7/ Plt 428
2/22/21: CT of thoracic spine with contrast: Increase in size of lesion behind C7-T3 vertebrae presently measuring 4.2 cm AP x 4cm
width prior size of 2.5cm AP x 2.2 cm width involving the muscles. The lesion extends to the left of T2 vertebra and into the spinal canal
causing spinal canal narrowing at T2-T3. It also causes severe bilateral neural foraminal narrowing, and may affect the bilateral exiting
nerves. Presently, it somewhat extends into subcutaneous space. This lesion causes pathologic fracture of spinous process of T2.
2/25/21: hs-CRP 15.2
¾/21: hs-CRP 7.5
3/6/21: ANA 0.20, Procalcitonin 0.17, Crea 0.50, eGFR-Crea 142.36, ALT 17, AST 24, Wbc 8.9, Neutro 80, Hgb 11.4, Hct 36.1, Plt 360, RBC 3.9
841 PS Massive ascites etiology to Diet DAT w/ SAP mgh Dr. Tia
72/F be determined IVF
Meds: Furosemide 20 mg PO, Ceftazidime 1 gm IV Q8 Dr. Ocampo/Amante/Hermogno
Labs:
3/17/21 WAB UTZ: Massive ascites
844-1 WN Partial Gut Obstruction Diet: NPO Abdominal Status Dr. Tia
DTR 58/F Secondary to Post Op IVF: PLR 1L x 8 hours Combiflex 1400 kcal x 24 hrs Monitoring
Adhesions s/p APR (2019) Meds: oxycodone + naloxone 10/5 q12 tramadol discontinued Dr. Orantia/Dr.Quitoy/Dr.Santos
3/22/21 Labs:
802 AS RCC, left, CAP-MR. COVID Diet: DAT w/ SAP Dr. Matias
ER 42/M suspect s/p thoracentesis IVF PLR 1L x 80 CC/HR
3/10/21 (3/18/21) Meds: Meropenem 1 g IV Q12, Tramadol 50mg/IV Q8.Metoclropormide 10mgIV q8, Ceftriaxone 2gm IV OD, Azithromycin 500mg pO OD, Tramadol Dr. A Perez
s/p Radical Nephrectomy 50mg IV q6 Dr. Ocampo/Quitoy/Hermogino
3/20/21 POD 8 Labs:
s/p 1 unit Prbc 3/11/21 : PT 14.2 vs 13.1/60%act/INR 1.22/PTT 21.8 vs 27.2 AST 22/ALT 15
3/10/21 wbc 8.1/S75/L13/hgb9.3/hct29.8/Platelte188
3/12/2021 Chest CT scan and WAB CT triphasic
Latest hgb 9.8 (9.3) Crea (1.4 (1.7)
818 MDC CAP-MR Diet: 1200 kcal in 6 equal feedings 1:1 dilution nutribest Dr. K. Seng E. Roxas / G. Arandia
36/F IVF: pNSS 1ll x 40 cc/hr
Meds: Enoxaparin 0.4 OD, Paracetmaol 300 mg IV Q6, NAC, Piptazo 4.5 gms IV Q8, Plactulose 30 cc ODHS, Levofloxacin 500 mg OD
Labs
726-2 HS Pleural Effusion, right sec to Diet DAT w SAP To place sinapi drain prior Dr. K. Tan / Dr. Francisco / Dr. Cabasas /
18/M infection s/p CTT insertion IVF: HL to discharge Dr. Albay
2/23/21 s/p streptokinase Meds:
fibrinolysis 3/2/21 Labs:
CCU(1)
740 SN 3v CAD Diet NPO FOR CABG Dr. S. Santos
DTR 60/M s/p CABG IVF 3/27/21
REF 3/16/21 Meds Dr. Amante/Quitoy/Santos
3/25/21 POD 2 Labs 4/4/0
IMU(0)
Mortalities
IMU 4 MQ Gallbladder Mass t/c Diet: NGT Feeding 30cc/hr Dr. Paner
DTR 54/F Malginancy; Cholelithaisis; IVF: Pnss 1L x 100 cc/hr Combiflex 1920 kcal x 24 hours Dr. Alvez
ONG, Right Hypertension; Meds: Metronidazole 500 mg IV Q8, Linezolid 600 mg IV Q12, Piptazo 4.5 gms IV Q8, Omepraole 40 mg IV OD, Tranexamic Acid 500 mg Q8, Vitamin SROD
3/14/21 s/p Appendectomy 1998 K 10 mg IV Q8 Dr. Ocampo/Dr. Hizon/Dr.Santos
s/p Biliary Enteric Bypass, Labs:
Salpingo-Oophorectomy, 3/22/21 CBC: wbc 38.4 (12.1) hgb 11.4 (11.5) hct 33.5 plt 116 (202)
bilateral 3/22/21 PTT 44 PT 21.9 PA 33.5 (31.3) INR 1.9 (2.09)
3/16/21 3/22/21 Crea 1.5 (1.1) BUN 44.1 (28.4) K 4.5 (3.73) Na 140 (136)
s/p Femoral line insertion, 3/22/21 CXR: bilateral pneumonia and/or pleural effusion, cardiomegaly, AA
right (3/21/21)
s/p revision of
hepaticojejunostomy
(3/21/21) POD 3
Discharges(7)
725-1 KM CCC Dr. Ramirez
DTR 25/M s/p lap chole (3/26/21)
3/26/21 POD1 Dr. Orantia/hizon/Hermogino